共 376 条
[1]
Neoptolemos JP(2004)A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200-1210
[2]
Stocken DD(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267-277
[3]
Friess H(2009)A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer Br J Cancer 101 908-915
[4]
Bassi C(2007)A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin Ann Surg Oncol 14 2088-2096
[5]
Dunn JA(2008)Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 3487-3495
[6]
Hickey H(2008)Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 3496-3502
[7]
Beger H(2009)Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer Ann Surg 250 88-95
[8]
Fernandez-Cruz L(1979)Colorectal carcinoma antigens detected by hybridoma antibodies Somatic Cell Genet 5 957-971
[9]
Dervenis C(1983)Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9 Clin Chem 29 549-552
[10]
Lacaine F(2000)Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice Eur J Surg Oncol 26 474-479